Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer. [electronic resource]
Producer: 20071017Description: 996-1002 p. digitalISSN:- 0008-543X
- Adenocarcinoma -- blood
- Administration, Oral
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Diarrhea -- chemically induced
- Diethylstilbestrol -- administration & dosage
- Drug Administration Schedule
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neoplasm Metastasis
- Paclitaxel -- administration & dosage
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Treatment Outcome
- Tubulin Modulators -- administration & dosage
- Venous Thrombosis -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.